Search

Browse Search Results

Athlete Outside with Fitness Tracker on a running track

Basic Page

FAQs

Find answers to commonly asked questions about OTC medicine, dietary supplement, and consumer medical device systems and regulations.

FDA headquarters sign in Washington DC

Press Releases and Statements

CHPA Statement Regarding Announcement of Patrizia Cavazzoni as FDA’s new CDER Director

CHPA congratulates Patrizia Cavazzoni on her recent appointment as director of FDA’s Center for Drug Evaluation and Research (CDER).

Apr 13, 2021

Video

CHPA Monthly Recap March 2021

Apr 7, 2021

Seniors reading medicine bottle labels in pharmacy

Article

CHPA CEO Shares 2021 Industry Outlook with Chain Drug Review

For its annual year-in-review series, Chain Drug Review featured CHPA's President & CEO, Scott Melville, who offered industry insights from last year and thoughts on the outlook for 2021.

Jan 7, 2021

Seniors reading medicine bottle labels in pharmacy

Press Releases and Statements

Senate Passes Over-the-Counter Monograph Reform Legislation

Dec 10, 2019

FDA headquarters sign in Washington DC

Basic Page

FAQs About Reforms to the OTC Monograph System
Seniors reading medicine bottle labels in pharmacy

Article

Timeline for Implementation of OTC Monograph Reform Fees Under Provisions in H.R. 748 (the CARES Act)

What follows is a timeline for implementation of OTC monograph reform under HR 748, also known as the CARES Act.

Jun 23, 2020

Filter Results

Reset
Automatic Submitted Filters